© Copyright 2026 American Medical Association. All rights reserved.
Immune globulins are specialized immunizing agents that provide effective, short-term, passive immunity to individuals. This type of immunity is termed "passive" because it does not require the recipient's immune system to actively produce antibodies; instead, the protection is conferred through the direct administration of antibodies. The antibodies in immune globulins are derived from a concentrated solution pooled from the blood of multiple human donors, ensuring a broad spectrum of antibody coverage. The specific code CPT® 90283 refers to human immune globulin (IgIV) that is administered intravenously, distinguishing it from other codes such as 90281, which pertains to intramuscular administration of human immune globulin. It is important to note that these codes are utilized solely to report the product used, rather than the clinical indications or circumstances under which the immune globulin is administered.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.